Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-line immunotherapy in non-small cell lung cancer: how to select and where to go.
Mogavero A, Cantale O, Mollica V, Anpalakhan S, Addeo A, Mountzios G, Friedlaender A, Kanesvaran R, Novello S, Banna GL. Mogavero A, et al. Among authors: cantale o. Expert Rev Respir Med. 2023 Dec;17(12):1191-1206. doi: 10.1080/17476348.2024.2302356. Epub 2024 Feb 9. Expert Rev Respir Med. 2023. PMID: 38294292 Review.
Assessing the role of colonic and other anatomical sites uptake by [18 F]FDG-PET/CT and immune-inflammatory peripheral blood indexes in patients with advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors.
Rizzo A, Cantale O, Mogavero A, Garetto L, Racca M, Venesio T, Anpalakhan S, Novello S, Gregorc V, Banna GL. Rizzo A, et al. Among authors: cantale o. Thorac Cancer. 2023 Aug;14(24):2473-2483. doi: 10.1111/1759-7714.15032. Epub 2023 Jul 13. Thorac Cancer. 2023. PMID: 37442801 Free PMC article.
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
Puliafito I, Chillari F, Russo A, Cantale O, Sciacca D, Castorina L, Colarossi C, Franchina T, Vitale MP, Ricciardi GRR, Adamo V, Esposito F, Giuffrida D. Puliafito I, et al. Among authors: cantale o. Front Endocrinol (Lausanne). 2023 Jan 30;14:1065599. doi: 10.3389/fendo.2023.1065599. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36793289 Free PMC article.
International Survey on Frailty Assessment in Patients with Cancer.
Banna GL, Cantale O, Haydock MM, Battisti NML, Bambury K, Musolino N, O'Carroll E, Maltese G, Garetto L, Addeo A, Gomes F. Banna GL, et al. Among authors: cantale o. Oncologist. 2022 Oct 1;27(10):e796-e803. doi: 10.1093/oncolo/oyac133. Oncologist. 2022. PMID: 35905085 Free PMC article.
Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study.
Banna GL, Cantale O, Muthuramalingam S, Cave J, Comins C, Cortellini A, Addeo A, Signori A, McKenzie H, Escriu C, Barone G, Chan S, Hicks A, Bainbridge H, Pinato DJ, Ottensmeier C, Gomes F. Banna GL, et al. Among authors: cantale o. Int Immunopharmacol. 2022 Sep;110:108985. doi: 10.1016/j.intimp.2022.108985. Epub 2022 Jun 28. Int Immunopharmacol. 2022. PMID: 35777264 Free article.
Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice.
Gagliano A, Prestifilippo A, Cantale O, Ferini G, Fisichella G, Fontana P, Sciacca D, Giuffrida D. Gagliano A, et al. Among authors: cantale o. Front Oncol. 2021 Jun 17;11:643155. doi: 10.3389/fonc.2021.643155. eCollection 2021. Front Oncol. 2021. PMID: 34221963 Free PMC article. Review.
Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non-Small Cell Lung Cancer With a PD-L1 Expression ≥50%.
Metro G, Banna GL, Signorelli D, Gili A, Galetta D, Galli G, Economopoulou P, Roila F, Friedlaender A, Camerini A, Christopoulou A, Cantale O, De Toma A, Pizzutilo P, Jimenez B, Collazo-Lorduy A, Calles A, Baxevanos P, Linardou H, Kosmidis P, Giannarelli D, Mountzios G, Addeo A. Metro G, et al. Among authors: cantale o. J Immunother. 2020 Nov/Dec;43(9):299-306. doi: 10.1097/CJI.0000000000000340. J Immunother. 2020. PMID: 32991393
Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab.
Banna GL, Signorelli D, Metro G, Galetta D, De Toma A, Cantale O, Banini M, Friedlaender A, Pizzutillo P, Garassino MC, Addeo A. Banna GL, et al. Among authors: cantale o. Transl Lung Cancer Res. 2020 Aug;9(4):1533-1542. doi: 10.21037/tlcr-19-583. Transl Lung Cancer Res. 2020. PMID: 32953525 Free PMC article.
13 results